企業プロフィール
Kenvue 株価・ニュース・カタリスト
- ティッカー:
- KVUE
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
17.20 USD (-0.12%)
終値
最終更新: 2026年10月2日
33.3B USD
時価総額
株価変動の要因
2026年10月2日 時点で KVUE の株価は小幅な動きにとどまり、$17.20 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Global Consumer Health Company
Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands. Its products are sold through pharmacies, mass merchants, grocery stores, e-commerce channels, and other retail outlets around the world.
Self Care Portfolio
The Self Care segment includes over-the-counter products for pain, allergy, digestive health, smoking cessation, and cough, cold, and flu. Major brands include Tylenol, Zyrtec, Pepcid, and Nicorette, supported by consumer marketing and healthcare-professional recognition.
Skin Health and Beauty
Skin Health and Beauty includes brands such as Neutrogena, Aveeno, and OGX. The business competes through dermatological positioning, product renovation, digital marketing, and new formulations across facial care, sun care, body care, and hair care.
Essential Health Brands
Essential Health covers oral care, wound care, baby care, and women's health. Listerine, Band-Aid, Johnson's, Stayfree, and related brands provide recurring demand across everyday categories and give Kenvue broad retail distribution.
Brand-Led Innovation Model
Kenvue combines established household brands with formulation, packaging, and claims innovation. Recent activity includes new Neutrogena and OGX products, Listerine formats, wound-care products, and an FDA-approved fixed-dose Tylenol and naproxen combination.
今後のカタリスト
- U.S. retail launch of Tylenol with Naproxen following FDA approval.
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。